Brief: Graphite Bio Shares Open 30% Above IPO Price In Nasdaq Debut

LENZ Therapeutics

25/06/2021 17:03

June 25 (Reuters) - 
    * GRAPHITE BIO SHARES OPEN AT $22.10 IN NASDAQ DEBUT VERSUS
IPO
PRICE OF $17.00/SHARE

Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))